World Health Day 2026
Defending health as a global public good
Strupat, Christoph / Srinivasa Srigiri / Paula von HaarenThe Current Column (2026)
Bonn: German Institute of Development and Sustainability (IDOS), The Current Column of 7 April 2026
Bonn, 07 April 2026. At a time of growing geopolitical fragmentation, the real test is whether governments uphold global health as a global public good, or reduce it to a bargaining chip.
On World Health Day 2026, the World Health Organization (WHO) calls on people everywhere to come “Together for health. Stand with science”. In the WHO’s framing, standing with science means not only respecting evidence, but also sustaining the cooperation and trust needed for effective global health action. That is the right message. But in a more fragmented geopolitical landscape, the real question is whether governments are still willing to defend the cooperation, fairness, and institutions on which the application of global health science depends.
Global health research can save lives, strengthen resilience, and generate substantial social and economic returns. However, these gains depend on countries being willing to share knowledge, build trust, and turn evidence into collective action. This has become increasingly difficult, as global health is under pressure from geopolitical rivalry, donor fragmentation, and more transactional forms of cooperation. In such settings, science itself risks being subordinated to bargaining power: data-sharing becomes conditional, surveillance politically contested, and research partnerships more asymmetric.
The United States’ withdrawal from the WHO and the recent bilateral health deals pursued by the Trump Administration illustrate how far the transactional logic of cooperation has advanced: global health is being recast from a field of solidarity into an instrument of geopolitical leverage. The US government has signed transactional health agreements with 14 African countries, raising serious concerns about sovereignty, data control, and health security. Yet partner countries are not without agency: Zambia resisted a proposal tying health funding to access to copper and cobalt, while judicial scrutiny in Kenya stalled implementation of a health deal with the United States. Transactional deal-making not only complicates cooperation to protect global health, but also erodes the multilateral basis for effective prevention and response to pandemics, antimicrobial resistance and climate-related health risks.
This shift has direct consequences for Germany’s own global health policy. In a more transactional global health landscape, the question is no longer whether Germany supports global health, but whether it also protects the conditions under which science can function across borders: data-sharing, trusted surveillance, collaborative research, and institutions that turn evidence into action. Seen in that light, the recent review of the Federal Government’s Global Health Strategy is highly relevant. It confirms the continued importance of global health and places stronger emphasis on prevention, climate-resilient health systems, pandemic preparedness, and multilateral health governance up to 2030. At the same time, the new BMZ strategy foresees that global health will be addressed more strongly through reform of the global health architecture, division of labour with other donors, and multilateral approaches. In principle, this is the right response to an increasingly fragmented global health landscape. Germany is right to defend multilateralism at a time when trust in international cooperation is under strain, and to link health more closely to resilience, prevention, and governance. The real test, however, is one of coherence: whether this higher level of ambition is matched by credible implementation. In practice, this means three things:
First, it requires moving beyond a traditional donor role towards a more reform-oriented approach. This can be done by using Germany’s financial and political weight not simply to preserve existing institutions, but to make global health organisations that translate scientific evidence into action, such as Gavi and the Global Fund, more equitable and better coordinated. This includes stronger collaboration across these organisations in line with the Lusaka Agenda, with a clearer focus on reducing fragmentation for partner countries.
Second, it means taking scientific research on the interlinkages of environmental and human health seriously, by integrating a One Health logic into implementation that links prevention and response more consistently with climate, water, and environmental health. Otherwise, the wider ecological and social drivers of health risk, from deforestation and biodiversity loss to climate change and intensive farming, will insufficiently be addressed.
Third, there are strong reasons to preserve bilateral engagement alongside multilateral efforts, particularly in fragile contexts where local anchoring, flexibility, and political responsiveness often prove essential. This matters not only for effective implementation, but also for the trusted relationships on which data-sharing and scientific cooperation frequently depend. In this way, Germany could combine multilateral strength with local responsiveness, especially where multilateral institutions alone cannot always react quickly enough.
World Health Day 2026 carries an important political message. To stand with science means more than praising evidence. It means defending the trust, fairness, and institutions that allow science to serve the common good. At a time of growing geopolitical fragmentation, the real test is whether governments are willing to treat global health not as a bargaining chip, but as a global public good.
